Vanguard Personalized Indexing Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.57M Buy
23,835
+3,110
+15% +$198K 0.02% 712
2025
Q4
$1.32M Buy
20,725
+2,641
+15% +$164K 0.01% 789
2025
Q3
$994K Buy
18,084
+4,493
+33% +$185K 0.01% 905
2025
Q2
$449K Buy
13,591
+1,509
+12% +$52.5K 0.01% 1245
2025
Q1
$486K Buy
12,082
+5,096
+73% +$234K 0.01% 1133
2024
Q4
$329K Buy
6,986
+305
+5% +$15.8K 0.01% 1298
2024
Q3
$353K Sell
6,681
-1,363
-17% -$76K 0.01% 1268
2024
Q2
$436K Sell
8,044
-638
-7% -$38.5K 0.01% 1096
2024
Q1
$609K Buy
8,682
+3,193
+58% +$247K 0.01% 907
2023
Q4
$458K Buy
+5,489
New +$199K 0.01% 1043

Other funds holding CYTK